BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 12730703)

  • 1. The etiology of erectile dysfunction and mechanisms by which drugs improve erection.
    Gallé G; Trummer H
    Drugs Today (Barc); 2003 Mar; 39(3):193-202. PubMed ID: 12730703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New treatment options for erectile dysfunction in patients with diabetes mellitus.
    Basu A; Ryder RE
    Drugs; 2004; 64(23):2667-88. PubMed ID: 15537369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacotherapeutic advances in the treatment of erectile dysfunction.
    Nehra A; Barrett DM; Moreland RB
    Mayo Clin Proc; 1999 Jul; 74(7):709-21. PubMed ID: 10405703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracavernosal injection and intraurethral therapy for erectile dysfunction.
    Leungwattanakij S; Flynn V; Hellstrom WJ
    Urol Clin North Am; 2001 May; 28(2):343-54. PubMed ID: 11402586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological treatment of erectile dysfunction.
    Moncada Iribarren I; Sáenz de Tejada I
    Curr Opin Urol; 1999 Nov; 9(6):547-51. PubMed ID: 10668576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of satisfactory rigidity after intracavernosal injection with prostaglandin E1 in men with erectile failure.
    Purvis K; Brekke I; Christiansen E
    Int J Impot Res; 1996 Mar; 8(1):9-16. PubMed ID: 8735188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacotherapy for erectile dysfunction.
    Bivalacqua TJ; Champion HC; Hellstrom WJ; Kadowitz PJ
    Trends Pharmacol Sci; 2000 Dec; 21(12):484-9. PubMed ID: 11121838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Future directions in erectile dysfunction therapy.
    Mulhall JP
    Postgrad Med; 2000 May; 107(6 Suppl Educational):19-23. PubMed ID: 19667519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current oral treatments for erectile dysfunction.
    Kalsi JS; Cellek S; Muneer A; Kell PD; Ralph DJ; Minhas S
    Expert Opin Pharmacother; 2002 Nov; 3(11):1613-29. PubMed ID: 12437495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical treatment of erectile dysfunction.
    Manecke RG; Mulhall JP
    Ann Med; 1999 Dec; 31(6):388-98. PubMed ID: 10680853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vasomax for the treatment of male erectile dysfunction.
    Goldstein I; Carson C; Rosen R; Islam A
    World J Urol; 2001 Feb; 19(1):51-6. PubMed ID: 11289571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of penile erection and basis for pharmacological treatment of erectile dysfunction.
    Andersson KE
    Pharmacol Rev; 2011 Dec; 63(4):811-59. PubMed ID: 21880989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Erectile dysfunction].
    Lyngdorf P
    Ugeskr Laeger; 2002 Oct; 164(41):4779-83. PubMed ID: 12407881
    [No Abstract]   [Full Text] [Related]  

  • 14. The hemodynamics of erection and the pharmacotherapies of erectile dysfunction.
    Melman A; Christ GJ
    Heart Dis; 2002; 4(4):252-64. PubMed ID: 12147185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracavernosal papaverine and phentolamine for the medical management of erectile dysfunction in a genitourinary clinic.
    Armstrong DK; Convery A; Dinsmore WW
    Int J STD AIDS; 1993; 4(4):214-6. PubMed ID: 8399501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update on oral treatments for male erectile dysfunction.
    Kalsi JS; Kell PD
    J Eur Acad Dermatol Venereol; 2004 May; 18(3):267-74. PubMed ID: 15096134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Current role of intracavernous therapy in the treatment of erectile dysfunction].
    Asuar Aydillo S
    Arch Esp Urol; 2002 Jun; 55(5):475-82. PubMed ID: 12174413
    [No Abstract]   [Full Text] [Related]  

  • 18. Combination therapy for erectile dysfunction: a randomized, double blind, unblinded active-controlled, cross-over study of the pharmacodynamics and safety of combined oral formulations of apomorphine hydrochloride, phentolamine mesylate and papaverine hydrochloride in men with moderate to severe erectile dysfunction.
    Lammers PI; Rubio-Aurioles E; Castell R; Castaneda J; Ponce de Leon R; Hurley D; Lipezker M; Loehr LA; Lowrey F
    Int J Impot Res; 2002 Feb; 14(1):54-9; discussion 60. PubMed ID: 11896479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erectile dysfunction: from biochemical pharmacology to advances in medical therapy.
    Maggi M; Filippi S; Ledda F; Magini A; Forti G
    Eur J Endocrinol; 2000 Aug; 143(2):143-54. PubMed ID: 10913932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostaglandin E1 with phentolamine for the treatment of erectile dysfunction.
    Meinhardt W; de la Fuente RB; Lycklama à Nijeholt AA; Vermeij P; Zwartendijk J
    Int J Impot Res; 1996 Mar; 8(1):5-7. PubMed ID: 8735187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.